Literature DB >> 26966175

Diabetes and risk of community-acquired Staphylococcus aureus bacteremia: a population-based case-control study.

Jesper Smit1, Mette Søgaard2, Henrik Carl Schønheyder3, Henrik Nielsen4, Trine Frøslev2, Reimar Wernich Thomsen2.   

Abstract

OBJECTIVE: Patients with diabetes may experience higher risk of Staphylococcus aureus bacteremia (SAB) than patients without diabetes due to decreased immunity or coexisting morbidities. We investigated the risk of community-acquired (CA) SAB in persons with and without diabetes.
DESIGN: Using population-based medical databases, we conducted a case-control study of all adults with first-time CA-SAB and matched population controls in Northern Denmark, 2000-2011.
METHODS: Based on conditional logistic regression, we computed odds ratios (ORs) of CA-SAB according to diabetes. We further assessed whether the risk of CA-SAB differed according to various diabetes-related characteristics (e.g. duration of diabetes, glycemic control, and presence of diabetes complications).
RESULTS: We identified 2638 patients with incident CA-SAB, of whom 713 (27.0%) had diabetes, and 26,379 matched population controls (2495 or 9.5% with diabetes). Individuals with diabetes had a substantially increased risk of CA-SAB compared with population controls (adjusted OR = 2.8 (95% confidence interval (CI): 2.5-3.1)). Duration of diabetes of ≥10 years and poor glycemic control conferred higher risk estimates, with an adjusted OR = 2.3 (95% CI: 1.9-2.7) for diabetes with Hba1c < 7% (< 53 mmol/mol) and an adjusted OR = 5.7 (95% CI: 4.2-7.7) for diabetes with Hba1c ≥9% (≥75 mmol/mol). The risk of CA-SAB was particularly high in patient with diabetes complications: adjusted OR = 5.5 (95% CI: 4.2-7.2) with presence of microvascular complications and OR = 7.0 (95% CI: 5.4-9.0) with combined macro- and microvascular complications.
CONCLUSIONS: Diabetes is associated with a substantially increased risk of CA-SAB, particularly in patients with diabetes of long duration, poor glycemic control, and diabetes complications.
© 2016 European Society of Endocrinology.

Entities:  

Mesh:

Year:  2016        PMID: 26966175     DOI: 10.1530/EJE-16-0023

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  14 in total

Review 1.  Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.

Authors:  Isaac P Thomsen; George Y Liu
Journal:  JCI Insight       Date:  2018-03-08

2.  Outcome of methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia: impact of diabetes.

Authors:  Anne Vanderschelden; Christophe Lelubre; Thibault Richard; Salah Eddine Lali; Soraya Cherifi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-05       Impact factor: 3.267

3.  Staphylococcus aureus drives expansion of low-density neutrophils in diabetic mice.

Authors:  Taylor S Cohen; Virginia Takahashi; Jessica Bonnell; Andrey Tovchigrechko; Raghothama Chaerkady; Wen Yu; Omari Jones-Nelson; Young Lee; Rajiv Raja; Sonja Hess; C Kendall Stover; John J Worthington; Mark A Travis; Bret R Sellman
Journal:  J Clin Invest       Date:  2019-04-15       Impact factor: 14.808

4.  Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study.

Authors:  T Eoin West; Chanthiwa Wikraiphat; Sarunporn Tandhavanant; Pitchayanant Ariyaprasert; Pornpan Suntornsut; Shawna Okamoto; Weera Mahavanakul; Pramot Srisamang; Sunchai Phiphitaporn; Jirasak Anukunananchai; Ploenchan Chetchotisakd; Sharon J Peacock; Narisara Chantratita
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

5.  Risk factors for Staphylococcus aureus bacteremia in patients with rheumatoid arthritis and incidence compared with the general population: protocol for a Danish nationwide observational cohort study.

Authors:  Sabine Sparre Dieperink; Bente Glintborg; Louise Bruun Oestergaard; Mette Nørgaard; Thomas Benfield; Frank Mehnert; Andreas Petersen; Merete Lund Hetland
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

6.  Increased Antimicrobial Resistance among Sputum Pathogens from Patients with Hyperglycemia.

Authors:  Huahua Yi; Jingwen Huang; Lingxi Guo; Qiurui Zhang; Jieming Qu; Min Zhou
Journal:  Infect Drug Resist       Date:  2020-06-11       Impact factor: 4.003

Review 7.  Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.

Authors:  Lloyd S Miller; Vance G Fowler; Sanjay K Shukla; Warren E Rose; Richard A Proctor
Journal:  FEMS Microbiol Rev       Date:  2020-01-01       Impact factor: 16.408

8.  Lack of nutritional immunity in diabetic skin infections promotes Staphylococcus aureus virulence.

Authors:  Lance R Thurlow; Amelia C Stephens; Kelly E Hurley; Anthony R Richardson
Journal:  Sci Adv       Date:  2020-11-13       Impact factor: 14.136

9.  Presence of egc-positive major clones ST 45, 30 and 22 among methicillin-resistant and methicillin-susceptible oral Staphylococcus aureus strains.

Authors:  Ewa Kwapisz; Katarzyna Garbacz; Maja Kosecka-Strojek; Justyna Schubert; Jacek Bania; Jacek Międzobrodzki
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

Review 10.  Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism.

Authors:  Christopher M Horn; Tammy Kielian
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.